Molecular epidemiology of respiratory syncytial virus

Reviews in Medical Virology

Volumn 28, Issue 2, 2018, Pages

  Pangesti, Krisna N A ^a   Abd El Ghany, Moataz ^b,c   Walsh, Michael G ^b,c   Kesson, Alison M ^b,c,d   Hill Cawthorne, Grant A ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c University of Sydney   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

genotype; molecular epidemiology; respiratory syncytial virus; whole genome

Indexed keywords

CLINICAL FEATURE; GENETIC VARIABILITY; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; MICROBIAL DIVERSITY; MOLECULAR EPIDEMIOLOGY; NONHUMAN; REVIEW; VIROLOGY; VIRUS CLASSIFICATION; WHOLE GENOME SEQUENCING; CLASSIFICATION; GENETIC VARIATION; GENOMICS; GENOTYPE; GEOGRAPHY; GLOBAL HEALTH; PHYLOGENY; PHYSIOLOGY; PROCEDURES; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS GENOME;

GENETIC VARIATION; GENOME, VIRAL; GENOMICS; GENOTYPE; GEOGRAPHY; GLOBAL HEALTH; HUMANS; PHYLOGENY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 85041131474     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1968     Document Type: Review

References (128)

1. Collins PL, Kerron RA. Respiratory Syncytial Virus and Metapneumovirus. In: Knipe DM, Howley PM, eds. Fields Virology. 6th ed. Philadelphia: Lippincott, Williams and Wilkins; 2013:1087-1123.
2. Shi T, McAllister DA, O'Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946-958.
3. Lee N, Lui GC, Wong KT, et al. High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis. 2013;57(8):1069-1077.
4. Modjarrad K, Giersing B, Kaslow DC, Smith PG, Moorthy VSWHO. Consultation on respiratory syncytial virus vaccine development report from a World Health Organization meeting held on 23-24 March 2015. Vaccine. 2016;34(2):190-197.
5. Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS. Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine. 2013;31(Suppl 2):B209-B215.
6. Anderson LJ. Respiratory syncytial virus vaccine development. Semin Immunol. 2013;25(2):160-171.
7. Sacco RE, Durbin RK, Durbin JE. Animal models of respiratory syncytial virus infection and disease. Curr Opin Virol. 2015;13:117-122.
8. Zhang ZY, Du LN, Chen X, et al. Genetic variability of respiratory syncytial viruses (RSV) prevalent in Southwestern China from 2006 to 2009: emergence of subgroup B and A RSV as dominant strains. J Clin Microbiol. 2010;48(4):1201-1207.
9. Venter M, Madhi SA, Tiemessen CT, Schoub BD. Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: identification of new subgroup A and B genotypes. J Gen Virol. 2001;82(9):2117-2124.
10. Sullender WM. Respiratory syncytial virus genetic and antigenic diversity. Clin Microbiol Rev. 2000;13(1):1-15.
11. Cane PA. Molecular epidemiology of respiratory syncytial virus. Rev Med Virol. 2001;11(2):103-116.
12. Collins PL, Graham BS. Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol. 2008;82(5):2040-2055.
13. Openshaw PJ. Immunity and immunopathology to respiratory syncytial virus. The mouse model. Am J Respir Crit Care Med. 1995;152(4_pt_2):S59-S62.
14. Collins PL, Fearns R, Graham BS. Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease. Curr Top Microbiol Immunol. 2013;372:3-38.
15. Collins PL, Melero JA. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res. 2011;162(1-2):80-99.
16. Spann KM, Tran KC, Chi B, Rabin RL, Collins PL. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J Virol. 2004;78(8):4363-4369.
17. Lo MS, Brazas RM, Holtzman MJ. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol. 2005;79(14):9315-9319.
18. Ramaswamy M, Shi L, Varga SM, Barik S, Behlke MA, Look DC. Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology. 2006;344(2):328-339.
19. Swedan S, Musiyenko A, Barik S. Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways. J Virol. 2009;83(19):9682-9693.
20. Bossert B, Conzelmann KK. Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J Virol. 2002;76(9):4287-4293.
21. Wright PF, Karron RA, Madhi SA, et al. The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans. J Infect Dis. 2006;193(4):573-581.
22. Bitko V, Shulyayeva O, Mazumder B, et al. Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth. J Virol. 2007;81(4):1786-1795.
23. Collins PL, Hill MG, Cristina J, Grosfeld H. Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proc Natl Acad Sci U S A. 1996;93(1):81-85.
24. Grosfeld H, Hill MG, Collins PLRNA. Replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA. J Virol. 1995;69(9):5677-5686.
25. Ghildyal R, Mills J, Murray M, Vardaxis N, Meanger J. Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J Gen Virol. 2002;83(4):753-757.
26. Feldman SA, Crim RL, Audet SA, Beeler JA. Human respiratory syncytial virus surface glycoproteins F, G and SH form an oligomeric complex. Arch Virol. 2001;146(12):2369-2383.
27. Melero JA, Garcia-Barreno B, Martinez I, Pringle CR, Cane PA. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein. J Gen Virol. 1997;78(10):2411-2418.
28. Kahn JS, Schnell MJ, Buonocore L, Rose JK. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology. 1999;254(1):81-91.
29. Bukreyev A, Whitehead SS, Murphy BR, Collins PL. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. J Virol. 1997;71(12):8973-8982.
30. Fuentes S, Tran KC, Luthra P, Teng MN, He B. Function of the respiratory syncytial virus small hydrophobic protein. J Virol. 2007;81(15):8361-8366.
31. Weinberger DM, Klugman KP, Steiner CA, Simonsen L, Viboud C. Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data. PLoS Med. 2015;12(1):e1001776
32. Stang P, Brandenburg N, Carter B. The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations. Arch Pediatr Adolesc Med. 2001;155(1):95-96.
33. Stockman LJ, Curns AT, Anderson LJ, Fischer-Langley G. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr Infect Dis J. 2012;31(1):5-9.
34. Hall CB, Weinberg GA, Blumkin AK, et al. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 2013;132(2):e341-e348.
35. Prill MM, Iwane MK, Little D, Gerber SI. Investigation of respiratory syncytial virus-associated deaths among US children aged <2 years, 2004-2007. J Pediatric Infect Dis Soc. 2016;5(3):333-336.
36. Ranmuthugala G, Brown L, Lidbury BA. Respiratory syncytial virus – the unrecognised cause of health and economic burden among young children in Australia. Commun Dis Intell Q Rep. 2011;35(2):177-184.
37. Meissner HC. Viral bronchiolitis in children. N Engl J Med. 2016;374(1):62-72.
38. Chanock RM, Kim HW, Vargosko AJ, et al. Respiratory syncytial virus. I. Virus recovery and other observations during 1960 outbreak of bronchiolitis, pneumonia, and minor respiratory diseases in children. JAMA. 1961;176:647-653.
39. Walsh EE. Respiratory syncytial virus infection in adults. Semin Respir Crit Care Med. 2011;32(4):423-432.
40. Walsh EE, Falsey AR, Hennessey PA. Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med. 1999;160(3):791-795.
41. Weber MW, Mulholland EK, Greenwood BM. Respiratory syncytial virus infection in tropical and developing countries. Trop Med Int Health. 1998;3(4):268-280.
42. Bloom-Feshbach K, Alonso WJ, Charu V, et al. Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review. PLoS One. 2013;8(2):e54445
43. Paynter S, Ware RS, Lucero MG, et al. Malnutrition: a risk factor for severe respiratory syncytial virus infection and hospitalization. Pediatr Infect Dis J. 2014;33(3):267-271.
44. Paynter S, Sly PD, Ware RS, Williams G, Weinstein P. The importance of the local environment in the transmission of respiratory syncytial virus. Sci Total Environ. 2014;493:521-525.
45. Paynter S. Humidity and respiratory virus transmission in tropical and temperate settings. Epidemiol Infect. 2015;143(6):1110-1118.
46. Kutsaya A, Teros-Jaakkola T, Kakkola L, et al. Prospective clinical and serological follow-up in early childhood reveals a high rate of subclinical RSV infection and a relatively high reinfection rate within the first 3 years of life. Epidemiol Infect. 2016;144(8):1622-1633.
47. Hall CB, Long CE, Schnabel KC. Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis. 2001;33(6):792-796.
48. O'Shea MK, Ryan MA, Hawksworth AW, Alsip BJ, Gray GC. Symptomatic respiratory syncytial virus infection in previously healthy young adults living in a crowded military environment. Clin Infect Dis. 2005;41(3):311-317.
49. Hall CB, Walsh EE, Long CE, Schnabel KC. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis. 1991;163(4):693-698.
50. Sande CJ, Mutunga MN, Okiro EA, Medley GF, Cane PA, Nokes DJ. Kinetics of the neutralizing antibody response to respiratory syncytial virus infections in a birth cohort. J Med Virol. 2013;85(11):2020-2025.
51. Ohuma EO, Okiro EA, Ochola R, et al. The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and disease. Am J Epidemiol. 2012;176(9):794-802.
52. Heise MT, Virgin HW. Pathogenesis of viral infection. In: Knipe DM, Howley PM, eds. Fields Virology. 6th ed. Philadelphia: Lippincott, Williams and Wilkins:255-285.
53. Openshaw PJ, Tregoning JS. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev. 2005;18(3):541-555.
54. Weber MW, Milligan P, Hilton S, et al. Risk factors for severe respiratory syncytial virus infection leading to hospital admission in children in the western region of the Gambia. Int J Epidemiol. 1999;28(1):157-162.
55. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr. 2003;143(5 Suppl):S118-S126.
56. DeVincenzo JP, Wilkinson T, Vaishnaw A, et al. Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am J Respir Crit Care Med. 2010;182(10):1305-1314.
57. El Saleeby CM, Bush AJ, Harrison LM, Aitken JA, Devincenzo JP. Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children. J Infect Dis. 2011;204(7):996-1002.
58. Thompson TM, Roddam PL, Harrison LM, Aitken JA, DeVincenzo JP. Viral specific factors contribute to clinical respiratory syncytial virus disease severity differences in infants. Clin Microbiol. 2015;4(3):206.
59. Mufson MA, Orvell C, Rafnar B, Norrby E. Two distinct subtypes of human respiratory syncytial virus. J Gen Virol. 1985;66(10):2111-2124.
60. Peret TC, Hall CB, Schnabel KC, Golub JA, Anderson LJ. Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol. 1998;79(9):2221-2229.
61. Yu X, Kou Y, Xia D, et al. Human respiratory syncytial virus in children with lower respiratory tract infections or influenza-like illness and its co-infection characteristics with viruses and atypical bacteria in Hangzhou, China. J Clin Virol. 2015;69:1-6.
62. Gimferrer L, Campins M, Codina MG, et al. Molecular epidemiology and molecular characterization of respiratory syncytial viruses at a tertiary care university hospital in Catalonia (Spain) during the 2013-2014 season. J Clin Virol. 2015;66:27-32.
63. Agoti CN, Mayieka LM, Otieno JR, et al. Examining strain diversity and phylogeography in relation to an unusual epidemic pattern of respiratory syncytial virus (RSV) in a long-term refugee camp in Kenya. BMC Infect Dis. 2014;14(1):178
64. Liu J, Mu Y, Dong W, et al. Genetic variation of human respiratory syncytial virus among children with fever and respiratory symptoms in Shanghai, China, from 2009 to 2012. Infect Genet Evol. 2014;27:131-136.
65. Trento A, Abrego L, Rodriguez-Fernandez R, et al. Conservation of G-protein epitopes in respiratory syncytial virus (group a) despite broad genetic diversity: is antibody selection involved in virus evolution? J Virol. 2015;89(15):7776-7785.
66. Houspie L, Lemey P, Keyaerts E, et al. Circulation of HRSV in Belgium: from multiple genotype circulation to prolonged circulation of predominant genotypes. PLoS One. 2013;8(4):e60416
67. Agoti CN, Otieno JR, Gitahi CW, Cane PA, Nokes DJ. Rapid spread and diversification of respiratory syncytial virus genotype ON1, Kenya. Emerg Infect Dis. 2014;20(6):950-959.
68. Tan L, Lemey P, Houspie L, et al. Genetic variability among complete human respiratory syncytial virus subgroup a genomes: bridging molecular evolutionary dynamics and epidemiology. PLoS One. 2012;7(12):e51439
69. Peret TC, Hall CB, Hammond GW, et al. Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis. 2000;181(6):1891-1896.
70. Venter M, Collinson M, Schoub BD. Molecular epidemiological analysis of community circulating respiratory syncytial virus in rural South Africa: comparison of viruses and genotypes responsible for different disease manifestations. J Med Virol. 2002;68(3):452-461.
71. Zlateva KT, Vijgen L, Dekeersmaeker N, Naranjo C, Van Ranst M. Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons. J Clin Microbiol. 2007;45(9):3022-3030.
72. Choi EH, Lee HJ. Genetic diversity and molecular epidemiology of the G protein of subgroups A and B of respiratory syncytial viruses isolated over 9 consecutive epidemics in Korea. J Infect Dis. 2000;181(5):1547-1556.
73. Sovero M, Garcia J, Kochel T, et al. Circulating strains of human respiratory syncytial virus in central and south America. PLoS One. 2011;6(8):e22111
74. Forcic D, Ivancic-Jelecki J, Mlinaric-Galinovic G, Vojnovic G, Babic-Erceg A, Tabain I. A study of the genetic variability of human respiratory syncytial virus in Croatia, 2006-2008. J Med Virol. 2012;84(12):1985-1992.
75. Kuroiwa Y, Nagai K, Okita L, et al. A phylogenetic study of human respiratory syncytial viruses group A and B strains isolated in two cities in Japan from 1980-2002. J Med Virol. 2005;76(2):241-247.
76. Khor CS, Sam IC, Hooi PS, Chan YF. Displacement of predominant respiratory syncytial virus genotypes in Malaysia between 1989 and 2011. Infect Genet Evol. 2013;14:357-360.
77. Trento A, Casas I, Calderon A, et al. Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene. J Virol. 2010;84(15):7500-7512.
78. Roca A, Loscertales MP, Quinto L, et al. Genetic variability among group A and B respiratory syncytial viruses in Mozambique: identification of a new cluster of group B isolates. J Gen Virol. 2001;82(1):103-111.
79. Dapat IC, Shobugawa Y, Sano Y, et al. New genotypes within respiratory syncytial virus group B genotype BA in Niigata, Japan. J Clin Microbiol. 2010;48(9):3423-3427.
80. van Niekerk S, Venter M. Replacement of previously circulating respiratory syncytial virus subtype B strains with the BA genotype in South Africa. J Virol. 2011;85(17):8789-8797.
81. Trento A, Galiano M, Videla C, et al. Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides. J Gen Virol. 2003;84(11):3115-3120.
82. Eshaghi A, Duvvuri VR, Lai R, et al. Genetic variability of human respiratory syncytial virus A strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication. PLoS One. 2012;7(3):e32807
83. Hirano E, Kobayashi M, Tsukagoshi H, et al. Molecular evolution of human respiratory syncytial virus attachment glycoprotein (G) gene of new genotype ON1 and ancestor NA1. Infect Genet Evol. 2014;28:183-191.
84. Ren L, Xia Q, Xiao Q, et al. The genetic variability of glycoproteins among respiratory syncytial virus subtype A in China between 2009 and 2013. Infect Genet Evol. 2014;27:339-347.
85. Cui G, Zhu R, Deng J, et al. Rapid replacement of prevailing genotype of human respiratory syncytial virus by genotype ON1 in Beijing, 2012-2014. Infect Genet Evol. 2015;33:163-168.
86. Duvvuri VR, Granados A, Rosenfeld P, Bahl J, Eshaghi A, Gubbay JB. Genetic diversity and evolutionary insights of respiratory syncytial virus A ON1 genotype: global and local transmission dynamics. Sci Rep. 2015;5(1):14268
87. Yamaguchi M, Sano Y, Dapat IC, et al. High frequency of repeated infections due to emerging genotypes of human respiratory syncytial viruses among children during eight successive epidemic seasons in Japan. J Clin Microbiol. 2011;49(3):1034-1040.
88. Sato M, Saito R, Sakai T, et al. Molecular epidemiology of respiratory syncytial virus infections among children with acute respiratory symptoms in a community over three seasons. J Clin Microbiol. 2005;43(1):36-40.
89. Mufson MA, Belshe RB, Orvell C, Norrby E. Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections. J Clin Microbiol. 1987;25(8):1535-1539.
90. Waris M. Pattern of respiratory syncytial virus epidemics in Finland: two-year cycles with alternating prevalence of groups A and B. J Infect Dis. 1991;163(3):464-469.
91. Parveen S, Broor S, Kapoor SK, Fowler K, Sullender WM. Genetic diversity among respiratory syncytial viruses that have caused repeated infections in children from rural India. J Med Virol. 2006;78(5):659-665.
92. Agoti CN, Mwihuri AG, Sande CJ, et al. Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural Kenya. J Infect Dis. 2012;206(10):1532-1541.
93. Scott PD, Ochola R, Sande C, et al. Comparison of strain-specific antibody responses during primary and secondary infections with respiratory syncytial virus. J Med Virol. 2007;79(12):1943-1950.
94. Savon C, Goyenechea A, Valdes O, et al. Respiratory syncytial virus group A and B genotypes and disease severity among Cuban children. Arch Med Res. 2006;37(4):543-547.
95. Walsh EE, McConnochie KM, Long CE, Hall CB. Severity of respiratory syncytial virus infection is related to virus strain. J Infect Dis. 1997;175(4):814-820.
96. Hall CB, Walsh EE, Schnabel KC, et al. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis. 1990;162(6):1283-1290.
97. Luchsinger V, Ampuero S, Palomino MA, et al. Comparison of virological profiles of respiratory syncytial virus and rhinovirus in acute lower tract respiratory infections in very young Chilean infants, according to their clinical outcome. J Clin Virol. 2014;61(1):138-144.
98. Prifert C, Streng A, Krempl CD, Liese J, Weissbrich B. Novel respiratory syncytial virus a genotype, Germany, 2011-2012. Emerg Infect Dis. 2013;19(6):1029-1030.
99. Panayiotou C, Richter J, Koliou M, Kalogirou N, Georgiou E, Christodoulou C. Epidemiology of respiratory syncytial virus in children in Cyprus during three consecutive winter seasons (2010-2013): age distribution, seasonality and association between prevalent genotypes and disease severity. Epidemiol Infect. 2014;142(11):2406-2411.
100. Kaplan NM, Dove W, Abd-Eldayem SA, Abu-Zeid AF, Shamoon HE, Hart CA. Molecular epidemiology and disease severity of respiratory syncytial virus in relation to other potential pathogens in children hospitalized with acute respiratory infection in Jordan. J Med Virol. 2008;80(1):168-174.
101. Esposito S, Piralla A, Zampiero A, et al. Characteristics and their clinical relevance of respiratory syncytial virus types and genotypes circulating in Northern Italy in five consecutive winter seasons. PLoS One. 2015;10(6):e0129369
102. Tabatabai J, Prifert C, Pfeil J, Grulich-Henn J, Schnitzler P. Novel respiratory syncytial virus (RSV) genotype ON1 predominates in Germany during winter season 2012-13. PLoS One. 2014;9(10):e109191
103. Pierangeli A, Trotta D, Scagnolari C, et al. Rapid spread of the novel respiratory syncytial virus A ON1 genotype, central Italy, 2011 to 2013. Euro Surveill. 2014;19(26):
104. Balmaks R, Ribakova I, Gardovska D, Kazaks A. Molecular epidemiology of human respiratory syncytial virus over three consecutive seasons in Latvia. J Med Virol. 2014;86(11):1971-1982.
105. Chi H, Liu HF, Weng LC, et al. Molecular epidemiology and phylodynamics of the human respiratory syncytial virus fusion protein in northern Taiwan. PLoS One. 2013;8(5):e64012
106. Baek YH, Choi EH, Song MS, et al. Prevalence and genetic characterization of respiratory syncytial virus (RSV) in hospitalized children in Korea. Arch Virol. 2012;157(6):1039-1050.
107. Boonyasuppayakorn S, Kowitdamrong E, Bhattarakosol P. Molecular and demographic analysis of respiratory syncytial virus infection in patients admitted to King Chulalongkorn Memorial Hospital, Thailand, 2007. Influenza Other Respi Viruses. 2010;4(5):313-323.
108. Martinello RA, Chen MD, Weibel C, Kahn JS. Correlation between respiratory syncytial virus genotype and severity of illness. J Infect Dis. 2002;186(6):839-842.
109. Rebuffo-Scheer C, Bose M, He J, et al. Whole genome sequencing and evolutionary analysis of human respiratory syncytial virus A and B from Milwaukee, WI 1998-2010. PLoS One. 2011;6(10):e25468
110. Connors M, Crowe JE Jr, Firestone CY, Murphy BR, Collins PLA. Cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes. Virology. 1995;208(2):478-484.
111. Tolley KP, Marriott AC, Simpson A, et al. Identification of mutations contributing to the reduced virulence of a modified strain of respiratory syncytial virus. Vaccine. 1996;14(17-18):1637-1646.
112. Firestone CY, Whitehead SS, Collins PL, Murphy BR, Crowe JE Jr. Nucleotide sequence analysis of the respiratory syncytial virus subgroup A cold-passaged (cp) temperature sensitive (ts) cpts-248/404 live attenuated virus vaccine candidate. Virology. 1996;225(2):419-422.
113. Crowe JE Jr, Bui PT, Firestone CY, et al. Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates. J Infect Dis. 1996;173(4):829-839.
114. Kumaria R, Iyer LR, Hibberd ML, Simoes EA, Sugrue RJ. Whole genome characterization of non-tissue culture adapted HRSV strains in severely infected children. Virol J. 2011;8(1):372
115. Tan L, Coenjaerts FE, Houspie L, et al. The comparative genomics of human respiratory syncytial virus subgroups A and B: genetic variability and molecular evolutionary dynamics. J Virol. 2013;87(14):8213-8226.
116. Mardis ER. Next-generation sequencing platforms. Annu Rev Annal Chem. 2013;6(1):287-303.
117. Bose ME, He J, Shrivastava S, et al. Sequencing and analysis of globally obtained human respiratory syncytial virus A and B genomes. PLoS One. 2015;10(3):e0120098
118. Schobel SA, Stucker KM, Moore ML, et al. Respiratory syncytial virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene. Sci Rep. 2016;6(1):26311
119. Agoti CN, Otieno JR, Munywoki PK, et al. Local evolutionary patterns of human respiratory syncytial virus derived from whole-genome sequencing. J Virol. 2015;89(7):3444-3454.
120. Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30(4):772-780.
121. Katoh K, Toh H. PartTree: an algorithm to build an approximate tree from a large number of unaligned sequences. Bioinformatics. 2007;23(3):372-374.
122. Collins PL, Dickens LE, Buckler-White A, et al. Nucleotide sequences for the gene junctions of human respiratory syncytial virus reveal distinctive features of intergenic structure and gene order. Proc Natl Acad Sci U S A. 1986;83(13):4594-4598.
123. Bukreyev A, Murphy BR, Collins PL. Respiratory syncytial virus can tolerate an intergenic sequence of at least 160 nucleotides with little effect on transcription or replication in vitro and in vivo. J Virol. 2000;74(23):11017-11026.
124. Harmon SB, Wertz GW. Transcriptional termination modulated by nucleotides outside the characterized gene end sequence of respiratory syncytial virus. Virology. 2002;300(2):304-315.
125. Lam TT, Hon CC, Tang JW. Use of phylogenetics in the molecular epidemiology and evolutionary studies of viral infections. Crit Rev Clin Lab Sci. 2010;47(1):5-49.
126. Vigerust DJ, Shepherd VL. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol. 2007;15(5):211-218.
127. Do LA, Wilm A, Van Doorn HR, et al. Direct whole-genome deep-sequencing of human respiratory syncytial virus A and B from Vietnamese children identifies distinct patterns of inter- and intra-host evolution. J Gen Virol. 2015;96(12):3470-3483.
128. Grad YH, Newman R, Zody M, et al. Within-host whole-genome deep sequencing and diversity analysis of human respiratory syncytial virus infection reveals dynamics of genomic diversity in the absence and presence of immune pressure. J Virol. 2014;88(13):7286-7293.